Home Cyto-Facto

Cyto-Facto

In operation
-
Contract Production Service Provider
Basic
Enterprise Profile

Basic Information

Cyto-Facto Inc., headquartered in Japan, provides contract manufacturing services for gene and cell preparations that comply with J-GMP and PIC/S GMP standards. Their services include process development, technology transfer, and GMP documentation maintenance. Additionally, they offer consulting on the manufacturing, commercialization, and quality control testing of CGT products, as well as integrated development of manufacturing management systems to ensure efficiency and compliance.
Cyto-Facto Inc.
Japan
51~100 people
October 18, 2022
--

Enterprise Profile

Industrial Sector
Production of Genetically Engineered Drugs CDMO
Technology
Gene Technology Cell Technology
Concept
Therapeutic Products
Application Scenarios
Cell and Gene Therapy